Drug Development Pipeline | Pharma Analysis

Pharmapremia gives you the ability to accurately benchmark internal and external R&D candidates’ chances of approval and potential development timelines. You can use these benchmarks to make informed decisions about drug pipeline prioritization, partnerships and acquisitions.

How it can help

Pharmapremia allows you to look at product success factors across the variables that matter to you and your business. Its robust dataset includes detailed information from the entire drug-development industry, from big pharma to private biotech, oncology to orphan diseases.

This data gives you an exclusive window into drug development pipelines and paints a fuller, clearer picture of how the industry is performing.

How it works

Effectively manage your portfolio risk by accessing comprehensive data sets including Probability of Overall Success (POS), Likelihood of Approval (LOA) and Phase and Overall Duration.

Pharmapremia covers over 8,000 programs including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.

Find out how Pharmapremia helps you ensure regulatory success and effectively manage portfolio risk in this video.

Request a demo

Datamonitor Healthcare, Biomedtracker, Pharmapremia

2019 Q3 Outlook Webinar

By Hardik Patel 16 Jul 2019

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.

Pharmapremia

Cancer Treatment is HARD!

11 Jun 2019

Drug development – it’s an area rife with risk, but with great risk often comes great rewards. An area notoriously prone to failure is oncology, and nowhere is accurate risk assessment more critical. Developing Cancer Treatments is HARD! But is everyone bad at it? is a view into this failure-prone area from Pharmapremia.

Pharmapremia

Oncology Success Rates Webinar Recording

21 Jul 2017

Presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.

Pharmapremia

Looking to benchmark internal and external R&D candidates’ chances of approval?

29 Jun 2017

Drill deeper into industry-standard data using peer-reviewed methodology to gain insights you can bank on. Pharmapremia can bring confidence to the accuracy of your benchmarks.

The data you need to make the right decisions

What's included

Below are the Feature List

Manage portfolio risks

Analyze success factors

Create meaningful benchmarks

Drug success rate methodology